Skip to content

In the BioHarmony Drug Report Database

Eteplirsen

Exondys (eteplirsen) is an oligonucleotide pharmaceutical. Eteplirsen was first approved as Exondys on 2016-09-19. It is used to treat duchenne muscular dystrophy in the USA. Exondys 51's patents are valid until 2034-03-14 (FDA).
Trade Name Exondys
Common Name Eteplirsen
Indication duchenne muscular dystrophy
Drug Class Antisense oligonucleotides
Eteplirsen
Get full access now